학술논문

Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial
Document Type
Article
Source
In: JAMA Oncology. (JAMA Oncology, 20 July 2023, 9(7):966-970)
Subject
Language
English
ISSN
23742445
23742437